This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Children who walk to school less likely to ... Children who regularly walk or cycle to school are less likely ... (20 May 2019)
Women with sleep apnoea are more likely to ... A study of more than 19,000 people has found that women with ... (20 May 2019)
Passion trumps love for sex in relationships When women distinguish between sex and the relational and ... (17 May 2019)
Inflammatory Bowel Disease During Childhood ... A new study revealed an increased risk of cancer and early death ... (13 May 2019)
Fracture Risk Tool Is Useful in Women with ... The FRAX®tool takes into account certain factors to determine ... (13 May 2019)

e-info Archive

Rate this item
(0 votes)
Relvar Ellipta SPC
Rate this item
(0 votes)
Muscoril 4mg hard capsules SmPC
Rate this item
(0 votes)
1981. Augmentin® – The first clavulanate-potentiated amoxicillin was launched for oral use2 LEADERS WALK IN FRONT 1. “The Wright Brothers - First Flight, 1903”, EyeWitness to History, www.eyewitnesstohistory.com (2003) accessed on 28 May 2014. 2. White AR et al. Augmentin™ (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent; Journal of Antimicrobial Chemotherapy 2004; 53:S1 i3-i20. Mini Abridged Prescribing Information: Please refer to full Summary of Product Characteristics (SPC) before prescribing. Trade Names: Augmentin ES 600 mg/42.9 mg/5 ml powder for oral suspension; Augmentin-Duo 400 mg/57 mg/ 5 ml Powder for Oral Suspension. Active Ingredients: Amoxicillin (as trihydrate) and potassium clavulanate. Pharmaceutical Form: Powder for oral suspension. Augmentin ES: Each 1 ml of oral suspension contains amoxicillin trihydrate equivalent to 120 mg amoxicillin and potassium clavulanate equivalent to 8.58 mg of clavulanic acid; Augmentin-Duo: Each 1 ml of reconstituted product contains amoxicillin trihydrate equivalent to 80 mg amoxicillin and potassium clavulanate equivalent to 11.4 mg of clavulanic acid. Indications: Augmentin ES/Augmentin Duo: For the treatment of acute otitis media and community acquired pneumonia infections caused or thought likely to be caused by penicillin-resistant Streptococcus pneumoniae. Refer to SPCs for…

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…